Rema Momin Bidanchi

Rema Momin Bidanchi

Auto-generated profile, based on publicly available information

Rema Momin Bidanchi

Department of Zoology, Mizoram University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2022 in Environmental Pollution
Verified
Journal Article
Closed access
RBRema Momin Bidanchi
Rema Momin Bidanchi
LLLalrinsanga Lalrindika
Lalrinsanga Lalrindika
MKMaurya Khushboo
Maurya Khushboo
BBBaishya Bhanushree
Baishya Bhanushree
DRDinata Roy
Dinata Roy
GGGuruswami Gurusubramanian
Guruswami Gurusubramanian

21 November 2024 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
DRDinata Roy
Dinata Roy
CAChettri Arati
Chettri Arati
ASAhmed-Laskar Saeed
Ahmed-Laskar Saeed
BMBose Manikandan
Bose Manikandan
GAGiri Abinash
Giri Abinash
GGGuruswami Gurusubramanian
Guruswami Gurusubramanian
Antimicrobial peptides (AMPs) are gaining popularity as potential substitutes for conventional antibiotics and bio-preservatives in response to an increase in antimicrobial resistance cases. However, their poor pharmacokinetic profiles limit their applicability. This study using ADMETlab, OECD QSAR toolbox, and VEGA HUB virtual environments profiled 82 peptide sequences of seven bee antimicrobial peptides (BAMPs: abaecin, apamin, apisimin, apidaecin, defensin, hymenoptaecin, and melittin) using 81 descriptors combining physicochemical, medicinal chemistry, ADMET, and toxicophore criteria. BAMPs adhere to key drug-like physicochemical features and drug-ability regulations set forth by pharmaceutical giants, including Lipinski, Pfizer, and GlaxoSmithKline. BAMPs have been predicted to demonstrate favorable cell permeability, high water solubility, oral bioavailability, no blood-brain barrier penetration, oral and intestinal absorption, excretion, and a high therapeutic index. They function as non-substrates of p-glycoprotein and do not alter the pharmacokinetic effects of P-gp substrates. None of BAMPs were found to inhibit cytochrome P450 enzymes, indicating their potential to promote drug clearance and metabolism. BAMPs are safe from adverse reactions, free of respiratory toxicity, hERG blockers, hepatotoxicity, sensitizers, carcinogens, and mutagens. They are non-corrosive, non-irritating to the eyes, non-bioaccumulative, non-ecotoxic, antibacterial, antifungal, and antiviral, low toxic with no toxicophore or PAINS alerts recorded. They are non-toxic to various receptors, including gonadal and stress receptors, PPAR-γ, mitochondrial membrane receptor, heat shock element, and p53. Seven BAMPs have been tested for their drug-like properties, supporting their potential as potential leads for the pharmaceutical and food industries as antimicrobial agents and bio-preservatives. Future studies should optimize bee peptide expression in biological systems.